Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparing a Nucleoside-Analogue-Sparing Regimen and a Protease-Inhibitor-Sparing Regimen in Patients With HIV. Influence on Morphological and Metabolic Disorders. A Randomized, Open-Label Multicenter Trial.

NCT00135460 is registered in ClinicalTrials.gov with Danish HIV Research Group as lead sponsor.

NCT NCT00135460
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00135460 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparing a Nucleoside-Analogue-Sparing Regimen and a Protease-Inhibitor-Sparing Regimen in Patients With HIV. Influence on Morphological and Metabolic Disorders. A Randomized, Open-Label Multicenter Trial.
Lead sponsor
Danish HIV Research Group
Phase
Phase 4
Overall status
Unknown status
Start date
June 30, 2003
Completion date
November 30, 2007
Enrollment
100
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-associated lipodystrophy syndrome